AKCEA THERAPEUTICS INC's ticker is AKCA and the CUSIP is 00972L107. A total of 1 filers reported holding AKCEA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $7,125,000 | +3229.4% | 392,768 | +2409.2% | 0.00% | – |
| Q2 2020 | $214,000 | -8.5% | 15,653 | -4.1% | 0.00% | – |
| Q1 2020 | $234,000 | -41.1% | 16,327 | -30.3% | 0.00% | – |
| Q4 2019 | $397,000 | +113.4% | 23,422 | +93.8% | 0.00% | – |
| Q3 2019 | $186,000 | -45.8% | 12,085 | -17.4% | 0.00% | – |
| Q2 2019 | $343,000 | -55.1% | 14,630 | -45.8% | 0.00% | -100.0% |
| Q1 2019 | $764,000 | +79.8% | 26,975 | +91.7% | 0.00% | – |
| Q4 2018 | $425,000 | +2.4% | 14,071 | +18.8% | 0.00% | – |
| Q3 2018 | $415,000 | +23.1% | 11,841 | -16.7% | 0.00% | – |
| Q2 2018 | $337,000 | -50.1% | 14,223 | -46.1% | 0.00% | -100.0% |
| Q1 2018 | $676,000 | +40.2% | 26,365 | -4.9% | 0.00% | – |
| Q4 2017 | $482,000 | +74.0% | 27,734 | +176.4% | 0.00% | – |
| Q3 2017 | $277,000 | – | 10,033 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 2,389,571 | $61,197,000 | 1.69% |
| Virtus ETF Advisers LLC | 39,351 | $1,008,000 | 0.88% |
| Eventide Asset Management | 175,000 | $4,482,000 | 0.21% |
| ALTRINSIC GLOBAL ADVISORS LLC | 187,800 | $4,810,000 | 0.19% |
| Bellevue Group AG | 48,799 | $1,250,000 | 0.12% |
| Perceptive Advisors | 97,144 | $2,488,000 | 0.07% |
| FMR LLC | 10,008,016 | $256,306,000 | 0.03% |
| WELLINGTON MANAGEMENT GROUP LLP | 3,384,101 | $86,667,000 | 0.02% |
| Virtu Financial LLC | 12,571 | $322,000 | 0.02% |
| Cubist Systematic Strategies, LLC | 7,843 | $201,000 | 0.01% |